help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on June 4, 2009, doi:10.1164/rccm.200812-1827OC

Am. J. Respir. Crit. Care Med., Volume 180, Number 4, August 2009, 326-338

A more recent version of this article appeared on August 15, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200812-1827OCv1
180/4/326    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Mitani, A.
Right arrow Articles by Kurihara, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitani, A.
Right arrow Articles by Kurihara, H.

Submitted on December 5, 2008
Accepted on June 2, 2009

Transcriptional Coactivator with PDZ-Binding Motif is Essential for Normal Alveolarization in Mice

Akihisa Mitani1, Takahide Nagase2*, Kazunori Fukuchi3, Hiroyuki Aburatani4, Ryosuke Makita5, and Hiroki Kurihara5

1 Department of Respiratory Medicine and Department of Physiological Chemistry and Metabolism, Graduate School of Medicine, University of Tokyo, Tokyo, Japan, 2 Department of Respiratory Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan, 3 Bioscience Division II, Discovery Research Laboratories, Kyorin Pharmaceutical CO., LTD, Nogi, Tochigi, Japan, 4 Genome Science Division, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan, 5 Department of Physiological Chemistry and Metabolism, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

* To whom correspondence should be addressed. E-mail: takahide-tky{at}umin.ac.jp.

Rationale: Transcriptional coactivator with PDZ-binding motif (TAZ) is assumed to act as a coactivator of several transcription factors including smad2/3. In the lung, surfactant protein C (Sftpc) is known to be a downstream target of thyroid transcription factor-1 (TTF-1) -TAZ transcriptional coactivation. Objectives: The lung phenotype of Taz-deficient mice was explored. Methods: Taz-deficient mice were analyzed pathologically and physiologically. Next, we performed microarray analysis in order to determine the genes closely related to abnormal lung development. Finally, Taz heterozygous mice were injected with bleomycin Measurements and Main Results: Taz-deficient homozygotes showed abnormal alveolarization during lung development, which caused in adult mice airspace enlargement mimicking emphysema. There was no significant difference in the expression of Sftpc between wild-type and Taz-deficient lungs. Instead, microarray analysis identified some candidate downstream genes related to the pathogenesis, including the connective tissue growth factor (Ctgf) gene, which is required for normal lung development. In vitro studies showed that TAZ up-regulated Ctgf expression by not only reinforcing TGF{beta}-smads signals, but also interfering more proximal Ctgf promoter region (from -123bp to -76bp), defined as TAZ response element. Furthermore, Taz heterozygous mice were resistant to bleomycin-induced lung fibrosis. Conclusions: The results indicate the importance of TAZ in lung alveolarization and its involvement in the pathogenesis of lung fibrosis.


Key words: Taz-deficient mice • emphysema • lung development • pulmonary fibrosis • connective tissue growth factor







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2009 American Thoracic Society
  CCM abstracts